Venture Life Group PLC Notice of Results (4554I)
01 Aprile 2020 - 4:10PM
UK Regulatory
TIDMVLG
RNS Number : 4554I
Venture Life Group PLC
01 April 2020
1 April 2020
Venture Life Group plc
("Venture Life" or the "Company")
Notice of Results
Venture Life (AIM: VLG), the international consumer self-care
group focused on developing, manufacturing and commercialising
products for the self-care market, today announces that it will
announce its preliminary results for the year ended 31 December
2019 on Thursday 9 April 2020.
For further information please contact:
Venture Life Group PLC +44 (0) 1344 578 004
Jerry Randall, Chief Executive Officer
Andrew Waters, Chief Financial Officer
Cenkos Securities plc (Nominated Adviser
and broker) +44 (0) 207 397 8900
Stephen Keys / Cameron MacRitchie (Corporate
Finance)
Russell Kerr / Michael Johnson (Sales)
Alma PR venturelife@almapr.com
or
+44 (0) 203 405 0208
Helena Bogle/Hilary Buchanan/Kieran
Breheny
About Venture Life ( www.venture-life.com )
Venture Life is an international consumer self-care company
focused on acquiring, developing, manufacturing and commercialising
products for the global self-care market. With operations in the
UK, Italy and the Netherlands, the Group's product portfolio
includes some key products such as the UltraDEX and Dentyl oral
care product ranges, , medical devices for dermatology, oral care,
women's intimate healthcare and proctology, and dermo-cosmetics for
addressing the signs of ageing.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies and grocery multiples. In the UK and the Netherlands
these are supplied direct by the company, elsewhere they are
supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy,
Biokosmes, the Group also provides development and manufacturing
services to companies in the OTC consumer products sector,
primarily in respect of medical devices.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORZFLFBBZLBBBE
(END) Dow Jones Newswires
April 01, 2020 10:10 ET (14:10 GMT)
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Apr 2023 a Apr 2024